1. Home
  2. VGZ vs VTGN Comparison

VGZ vs VTGN Comparison

Compare VGZ & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vista Gold Corp

VGZ

Vista Gold Corp

HOLD

Current Price

$1.95

Market Cap

263.8M

Sector

N/A

ML Signal

HOLD

Logo VistaGen Therapeutics Inc.

VTGN

VistaGen Therapeutics Inc.

HOLD

Current Price

$0.65

Market Cap

28.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VGZ
VTGN
Founded
1983
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
263.8M
28.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VGZ
VTGN
Price
$1.95
$0.65
Analyst Decision
Strong Buy
Hold
Analyst Count
1
3
Target Price
$3.00
$0.90
AVG Volume (30 Days)
1.8M
6.1M
Earning Date
11-12-2025
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$721,000.00
Revenue This Year
N/A
$54.26
Revenue Next Year
N/A
$478.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$0.63
52 Week High
$2.47
$5.14

Technical Indicators

Market Signals
Indicator
VGZ
VTGN
Relative Strength Index (RSI) 47.44 22.79
Support Level $2.03 $0.65
Resistance Level $2.38 $0.75
Average True Range (ATR) 0.17 0.18
MACD -0.03 -0.19
Stochastic Oscillator 9.73 0.57

Price Performance

Historical Comparison
VGZ
VTGN

About VGZ Vista Gold Corp

Vista Gold Corp is a gold mining company. It is engaged in the evaluation, acquisition, exploration, and advancement of gold exploration and potential development projects. The company evaluate, acquire, explore and advance gold exploration and potential development projects for gold production or value adding strategic transactions. The Company has one reportable segment: Australia. The Australia segment conducts exploration, development, care and maintenance activities at Vista's asset, the Mt Todd gold project in Northern Territory, Australia.

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Share on Social Networks: